Jyothy Labs Limited
Jyothy Labs Limited Fundamental Analysis
Jyothy Labs Limited (JYOTHYLAB.NS) shows moderate financial fundamentals with a PE ratio of 26.21, profit margin of 11.73%, and ROE of 18.42%. The company generates $29.2B in annual revenue with moderate year-over-year growth of 3.88%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 60.7/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze JYOTHYLAB.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentJYOTHYLAB.NS demonstrates superior asset utilization.
Valuation Score
ModerateJYOTHYLAB.NS shows balanced valuation metrics.
Growth Score
WeakJYOTHYLAB.NS faces weak or negative growth trends.
Financial Health Score
ExcellentJYOTHYLAB.NS maintains a strong and stable balance sheet.
Profitability Score
WeakJYOTHYLAB.NS struggles to sustain strong margins.
Key Financial Metrics
Is JYOTHYLAB.NS Expensive or Cheap?
P/E Ratio
JYOTHYLAB.NS trades at 26.21 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, JYOTHYLAB.NS's PEG of -14.63 indicates potential undervaluation.
Price to Book
The market values Jyothy Labs Limited at 6.23 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.32 times EBITDA. This signals the market has high growth expectations.
How Well Does JYOTHYLAB.NS Make Money?
Net Profit Margin
For every $100 in sales, Jyothy Labs Limited keeps $11.73 as profit after all expenses.
Operating Margin
Core operations generate 21.10 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.42 in profit for every $100 of shareholder equity.
ROA
Jyothy Labs Limited generates $16.12 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Jyothy Labs Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Jyothy Labs Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
JYOTHYLAB.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
26.21
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-14.63
vs 25 benchmark
P/B Ratio
Price to book value ratio
6.23
vs 25 benchmark
P/S Ratio
Price to sales ratio
3.07
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.04
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.79
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.16
vs 25 benchmark
ROCE
Return on capital employed
0.39
vs 25 benchmark
How JYOTHYLAB.NS Stacks Against Its Sector Peers
| Metric | JYOTHYLAB.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 26.21 | 22.76 | Worse (Expensive) |
| ROE | 18.42% | 1266.00% | Weak |
| Net Margin | 11.73% | -6316.00% (disorted) | Strong |
| Debt/Equity | 0.04 | 0.79 | Strong (Low Leverage) |
| Current Ratio | 2.79 | 2.41 | Strong Liquidity |
| ROA | 16.12% | -200217.00% (disorted) | Strong |
JYOTHYLAB.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Jyothy Labs Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
67.59%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthEPS CAGR
117.46%
Industry Style: Defensive, Dividend, Low Volatility
High GrowthFCF CAGR
81.61%
Industry Style: Defensive, Dividend, Low Volatility
High Growth